Do you boost a breast cavity for a high Ki-67 index in the absence of other risk factors?  

Ki-67 has some level of subjectivity with inter-individual variation. If genomic testing, like Oncotype or Mammaprint, has been done, I would favor using that to decide whether the patient is low risk or not over k1-67 alone.